Opyn Health Acquires AI Benefits Platform Empara

October 29, 2025
Opyn Health has acquired Empara, an AI-driven benefits engagement and administration platform, to create a unified, end-to-end benefits solution for self-funded health plans.

Opyn Health, Inc. has acquired Empara, an AI-led benefits engagement and administration platform, announced in a press release. The deal aims to combine Opyn’s price transparency and virtual care tools with Empara’s intelligent platform to deliver an integrated benefits administration experience.

The combined offering will provide members with a single, AI-driven interface that consolidates healthcare tools for easier access and management. For administrators, the integration is designed to streamline operations, reduce manual tasks, and improve service efficiency.

Empara was developed within the Goodroot community and focuses on simplifying benefits engagement through automation and user-friendly design. Following the acquisition, Empara’s founders Markus Waite, Ben Callaghan, and Mike Nigels will join Opyn Health to apply their AI expertise across Opyn’s data and digital health services. The unified platform will be available to third-party administrators, brokers, and self-insured employers.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

12/20
SoftBank Races to Complete $22.5 Billion OpenAI Funding by Year-End
12/19
OpenAI Reportedly Targeting $100 Billion Raise at $830 Billion Valuation
12/19
Yann LeCun Plans $3.5 Billion AI Startup After Leaving Meta
12/19
Salesforce to Acquire Qualified to Expand Agentic AI Marketing Capabilities
12/18
Lovable Raises $330 Million Series B at $6.6 Billion Valuation

More from: Life Sciences

12/17
AllOne Health Acquires Three EAP Providers to Expand National Reach
12/17
UbiSim Adds AI Narrative Analysis to Streamline Nursing Education
12/17
Caris Life Sciences and Genentech Partner on Cancer Target Discovery
12/16
Chai Discovery Raises $130 Million for AI Molecule Design
12/08
Michael J. Fox Foundation Launches Target Validation Program for Parkinson’s Therapies

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

Superagency in the Workplace: Empowering People to Unlock AI’s Full Potential

This report explores the transformative potential of artificial intelligence in the workplace, emphasizing the readiness of employees versus the slower adaptation of leadership. It highlights the significant productivity growth potential AI offers, akin to historical technological shifts, and discusses the barriers to achieving AI maturity within organizations. The report also examines the role of leadership in steering companies towards effective AI integration and the need for strategic investments to harness AI's full capabilities.

Read more

You May Also Like